Dermatologic Drugs During Pregnancy and Lactation

Katherine B. Lee; Teri M. Greiling

doi:10.1016/B978-0-323-61211-1.00065-6

Dermatologic Drugs During Pregnancy and Lactation

Katherine B. Lee, Teri M. Greiling

Dermatology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This chapter identifies and discusses recommendations and contraindications to various drugs in pregnancy and lactation. When treatment with one of these drugs is essential, data must be carefully examined and evaluated, so that a risk–benefit ratio may be determined. In addition, the benefits of breastfeeding are numerous, so any decision to limit breastfeeding must be justified by the fact that the risk to the baby clearly outweighs the benefits offered by breastfeeding. It is crucial to have both patient and physician take part in the decision-making process.

Original language	English (US)
Title of host publication	Comprehensive Dermatologic Drug Therapy, Fourth Edition
Publisher	Elsevier
Pages	710-724.e4
ISBN (Electronic)	9780323612111
ISBN (Print)	9780323612128
DOIs	https://doi.org/10.1016/B978-0-323-61211-1.00065-6
State	Published - Jan 1 2020

Keywords

breastfeeding
drugs
lactation
pregnancy
toxicity

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/B978-0-323-61211-1.00065-6

Cite this

@inbook{a5ed85e77ab348989c5d778d7ceaf2f6,

title = "Dermatologic Drugs During Pregnancy and Lactation",

abstract = "This chapter identifies and discusses recommendations and contraindications to various drugs in pregnancy and lactation. When treatment with one of these drugs is essential, data must be carefully examined and evaluated, so that a risk–benefit ratio may be determined. In addition, the benefits of breastfeeding are numerous, so any decision to limit breastfeeding must be justified by the fact that the risk to the baby clearly outweighs the benefits offered by breastfeeding. It is crucial to have both patient and physician take part in the decision-making process.",

keywords = "breastfeeding, drugs, lactation, pregnancy, toxicity",

author = "Lee, {Katherine B.} and Greiling, {Teri M.}",

year = "2020",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-61211-1.00065-6",

language = "English (US)",

isbn = "9780323612128",

pages = "710--724.e4",

booktitle = "Comprehensive Dermatologic Drug Therapy, Fourth Edition",

publisher = "Elsevier",

}

TY - CHAP

T1 - Dermatologic Drugs During Pregnancy and Lactation

AU - Lee, Katherine B.

AU - Greiling, Teri M.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - This chapter identifies and discusses recommendations and contraindications to various drugs in pregnancy and lactation. When treatment with one of these drugs is essential, data must be carefully examined and evaluated, so that a risk–benefit ratio may be determined. In addition, the benefits of breastfeeding are numerous, so any decision to limit breastfeeding must be justified by the fact that the risk to the baby clearly outweighs the benefits offered by breastfeeding. It is crucial to have both patient and physician take part in the decision-making process.

AB - This chapter identifies and discusses recommendations and contraindications to various drugs in pregnancy and lactation. When treatment with one of these drugs is essential, data must be carefully examined and evaluated, so that a risk–benefit ratio may be determined. In addition, the benefits of breastfeeding are numerous, so any decision to limit breastfeeding must be justified by the fact that the risk to the baby clearly outweighs the benefits offered by breastfeeding. It is crucial to have both patient and physician take part in the decision-making process.

KW - breastfeeding

KW - drugs

KW - lactation

KW - pregnancy

KW - toxicity

UR - http://www.scopus.com/inward/record.url?scp=85143703895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143703895&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-61211-1.00065-6

DO - 10.1016/B978-0-323-61211-1.00065-6

M3 - Chapter

AN - SCOPUS:85143703895

SN - 9780323612128

SP - 710-724.e4

BT - Comprehensive Dermatologic Drug Therapy, Fourth Edition

PB - Elsevier

ER -

Dermatologic Drugs During Pregnancy and Lactation

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this